Sector portfolio · VC firm · United States
Longitude Capital's Biotech portfolio
Longitude Capital has backed 30 Biotech startups in rounds we track, $2.7B between them, shown by the stage each has reached. The best-funded is 89bio.
Longitude Capital's whole portfolioLongitude Capital's profile
Funding by segment
- Series C and later$887M9
- Stage not reported$618M8
- Series A$940M7
- Series B$246M6
Where they are based
- United States26$2.3B
- Switzerland1$194M
- United Kingdom1$33M
- Canada1$70M
- Ireland1$64M
United States
Switzerland
United Kingdom
Canada
IrelandFounded
11 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M9
- $50M to $250M19
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
19 of 30 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States26
- Switzerland1
- United Kingdom1
- Canada1
- Ireland1
Startups by country, 5 countries in all.
Segment by segment
Series C and later
9 startups · $887M raised
Alentis TherapeuticsAlentis Therapeutics is a clinical-stage biotechnology company based in Basel, Switzerland.Switzerland$194M- SSutroVaxUnited States$167M
Quanta TherapeuticsQuanta Therapeutics, Inc.United States$127M
Civitas TherapeuticsCivitas develops pulmonary delivery therapies.United States$122M- BBAROnovaBAROnova is a Silicon Valley based venture-backed company that has developed a novel non-surgical solution for obesity.United States$85M
CeribellCeribell focuses on making electroencephalography accessible, efficient, and cost-effective.United States$85M- TTricadaUnited States$55M
- KKaNDYUnited Kingdom$33M
Stage not reported
8 startups · $618M raised
Vera TherapeuticsVera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.United States$261M- VCVenus ConceptCanada$70M
- SSublimityIreland$64M
- CCydanUnited States$60M
- RMRapid MicroUnited States$60M
Rivus PharmaceuticalsRivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.United States$57M
- AMAmphora MedicalAmphora Medical is a Minnesota-based developer of medical devices and instruments.United States$36M
- ZTZavante TherapeuticsZavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.United States$10M
Series A
7 startups · $940M raised
89Bio89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.United States$348M
AirNexis TherapeuticsAirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.United States$200M- IPInozyme PharmaUnited States$116M
Talaris TherapeuticsTalaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies.United States$100M
Epirium BioEpirium Bio is a clinical-stage biopharmaceutical company based in San Diego, California.United States$85M- NNeuranaUnited States$60M
- TTTiburio TherapeuticsTiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.United States$31M
Series B
6 startups · $246M raised
Lassen TherapeuticsLassen Therapeutics is a clinical-stage biopharmaceutical company based in San Diego, California.United States$85M
AptinyxAptinyx Inc.United States$76M
WelbeHealthWelbeHealth is a physician-led healthcare company founded in 2015, dedicated to providing comprehensive care for medically frail sUnited States$30M- VTVelicept TherapeuticsVelicept Therapeutics is a privately held clinical developmentUnited States$27M
- VVeliceptUnited States$15M
MurjMurj is a digital health company located in Santa Cruz, California, specializing in cloud-based software solutions for managing caUnited States$13M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Longitude Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Longitude Capital?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.